Endocrine Society Advances Key Priorities at AMA Annual Meeting

On June 10 – 15, the American Medical Association (AMA) House of Delegates met to establish policy positions on topics of importance to healthcare providers and patients. Endocrine Society delegates Amanda Bell, MD, and Palak Choksi, MD, successfully advocated for several of our key policy priorities, including insulin affordability, obesity, women’s health, climate change, and...

Endocrine Society Advises EU Policymakers on Chemicals Strategy 

As part of our global advocacy for science-based policies to reduce exposure to harmful endocrine-disrupting chemicals (EDCs), the Endocrine Society has a seat on an advisory body to the European Commission on the implementation of the Chemicals Strategy for Sustainability (CSS). On May 18, members of the advisory met in Brussels, Belgium, to adopt a...

The Endocrine Society is Advocating for You 

Learn more about our advocacy and how you can get involved Today’s political environment is partisan, turbulent, and hard to navigate. Despite this challenge, the Endocrine Society works with the U.S. Congress, the White House, federal agencies, and global policymakers to influence the legislative and regulatory policies affecting endocrine-related research and practice. We advocate for...

Endocrine Society Advocates for Increased NIH Funding

Join our online campaign to share our message with your representative and senators The U.S. Congress is currently considering funding for fiscal year (FY) 2023, which begins October 1. The Endocrine Society is urging Congress to provide $50 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2023, a 7.9% increase from...

Advocacy Season for NIH Funding Officially Begins

While 2022 is only a few months old, on Capitol Hill the appropriations cycle for fiscal year (FY) 2023 is well and truly underway and the Endocrine Society has quickly shifted gears and developed our 2023 funding requests for the NIH and other critical public health agencies. In March, the Biden Administration kicked off the...

Endocrine Society Members Advocate for Insulin Affordability, Diabetes Prevention, Diabetes Research

The Endocrine Society conducted a Hill Day over April 26, 27, and 28, where we brought together nearly 55 member clinicians, clinical researchers, and basic scientists from 25 states to meet with their Congressional representatives and discuss issues related to diabetes treatment, prevention, and research. Continuing security restrictions on Capitol Hill required that our meetings...

Final Fiscal Year 2022 Appropriations Legislation Passed with Increase for NIH, CDC, and Other Programs 

Following intense negotiations, in March the House and Senate finally passed an appropriations package that funded the federal government for Fiscal Year (FY) 2022, which technically began October 1, 2021. The $1.5-trillion package received bipartisan support and follows months of advocacy by the Endocrine Society with increased funding for our priorities. The bill includes several important...

Biden Continues Focus on ARPA-H, Cancer Moonshot as Francis Collins Takes on New Role

President Joe Biden has named retired National Institutes of Health director Francis Collins to be the president’s top science adviser until permanent leadership is nominated and confirmed. Eric Lander who formerly led the Office of Science and Technology Programs (OSTP) and held the cabinet-level position of science adviser resigned after it became public that an...

Endocrinology Advocacy

Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.

Important Advocacy Information From the Endocrine Society

As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.

Both Clinical and Research Advocacy Information

On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.